Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sernova Corp (SVA.TO)

Sernova Corp (SVA.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 45,454
  • Shares Outstanding, K 336,699
  • Annual Sales, $ 0 K
  • Annual Income, $ -15,743 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.73
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings $-0.01 on N/A
  • Next Earnings Date 12/22/25
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 01/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +4,995,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1200 +8.33%
on 12/29/25
0.1600 -18.75%
on 12/01/25
-0.0250 (-16.13%)
since 11/28/25
3-Month
0.1200 +8.33%
on 12/29/25
0.1900 -31.58%
on 10/06/25
-0.0500 (-27.78%)
since 09/30/25
52-Week
0.1200 +8.33%
on 12/29/25
0.2600 -50.00%
on 01/03/25
-0.0900 (-40.91%)
since 12/30/24

Most Recent Stories

More News
Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine...

SVA.TO : 0.1300 (-3.70%)
Stocks in play: Sernova Biotherapeutics

Today announced that it has signed debt-to-equity conversion agreements with vendors to convert approximately ...

SVA.TO : 0.1300 (-3.70%)
Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused...

SVA.TO : 0.1300 (-3.70%)
SEOVF : 0.0943 (+1.73%)
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

ELDN : 1.5000 (-0.66%)
SVA.TO : 0.1300 (-3.70%)
SEOVF : 0.0943 (+1.73%)
Sernova Appoints Jonathan Rigby as Interim Chair

SVA.TO : 0.1300 (-3.70%)
SEOVF : 0.0943 (+1.73%)
Chair of Sernova Biotherapeutics Resigns

SVA.TO : 0.1300 (-3.70%)
SEOVF : 0.0943 (+1.73%)
Stocks in play: Sernova Biotherapeutics

Announced the formation of its Clinical Advisory Board. The board will consist of five members and will ...

SVA.TO : 0.1300 (-3.70%)
Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes

SVA.TO : 0.1300 (-3.70%)
SEOVF : 0.0943 (+1.73%)
Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

SVA.TO : 0.1300 (-3.70%)
SEOVF : 0.0943 (+1.73%)
Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans

SVA.TO : 0.1300 (-3.70%)
SEOVF : 0.0943 (+1.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the...

See More

Key Turning Points

3rd Resistance Point 0.1483
2nd Resistance Point 0.1417
1st Resistance Point 0.1383
Last Price 0.1300
1st Support Level 0.1283
2nd Support Level 0.1217
3rd Support Level 0.1183

See More

52-Week High 0.2600
Fibonacci 61.8% 0.2065
Fibonacci 50% 0.1900
Fibonacci 38.2% 0.1735
Last Price 0.1300
52-Week Low 0.1200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar